航空航天医学杂志
航空航天醫學雜誌
항공항천의학잡지
Journal of Aerospace Medicine
2015年
10期
1183-1185
,共3页
肖治宇%王立群%师文静%王成轾%吴永辉%史哲%徐九根%赵辉%高华英
肖治宇%王立群%師文靜%王成輊%吳永輝%史哲%徐九根%趙輝%高華英
초치우%왕립군%사문정%왕성지%오영휘%사철%서구근%조휘%고화영
死亡病例%胆碱酯酶%预后判断%相关
死亡病例%膽堿酯酶%預後判斷%相關
사망병례%담감지매%예후판단%상관
Deaths%Cholinesterase%Prognosis%Correlation
目的 探讨血清胆碱酯酶变化与临床预后之间相关性. 方法 分析2009-12~2014-12住院死亡1099例,资料完整884例,分肿瘤与非肿瘤组,按系统分析患者死亡前3周及1周血清胆碱酯酶与肝功能变化数值,进行统计学处理,P<0.05为差异显著. 结果 全部死亡病例胆碱酯酶下降明显( P<0.05 ) ,尤其是乳腺癌患者(P<0.001).胆碱酯酶升高46例,占5.2%. 全部死亡病例除食管、 胃癌及血液骨髓肿瘤,、外伤及泌尿生殖系统疾病谷丙转氨酶变化不明显 ( P>0.05 ) ,余均差异显著( P<0.05 ). 192例肝功能正常,占23.8%. 结论 血清胆碱酯酶持续下降,特别是下降幅度大于30%,提示预后不良. 血清胆碱酯酶测定可作为临床病情监测与判断预后的一种指标,值得推广应用及进一步研究. 其下降机制可能与肝肾功能受损、炎症反应及机体主动调节有关. 胆碱酯酶升高机制不明,需进一步探讨.
目的 探討血清膽堿酯酶變化與臨床預後之間相關性. 方法 分析2009-12~2014-12住院死亡1099例,資料完整884例,分腫瘤與非腫瘤組,按繫統分析患者死亡前3週及1週血清膽堿酯酶與肝功能變化數值,進行統計學處理,P<0.05為差異顯著. 結果 全部死亡病例膽堿酯酶下降明顯( P<0.05 ) ,尤其是乳腺癌患者(P<0.001).膽堿酯酶升高46例,佔5.2%. 全部死亡病例除食管、 胃癌及血液骨髓腫瘤,、外傷及泌尿生殖繫統疾病穀丙轉氨酶變化不明顯 ( P>0.05 ) ,餘均差異顯著( P<0.05 ). 192例肝功能正常,佔23.8%. 結論 血清膽堿酯酶持續下降,特彆是下降幅度大于30%,提示預後不良. 血清膽堿酯酶測定可作為臨床病情鑑測與判斷預後的一種指標,值得推廣應用及進一步研究. 其下降機製可能與肝腎功能受損、炎癥反應及機體主動調節有關. 膽堿酯酶升高機製不明,需進一步探討.
목적 탐토혈청담감지매변화여림상예후지간상관성. 방법 분석2009-12~2014-12주원사망1099례,자료완정884례,분종류여비종류조,안계통분석환자사망전3주급1주혈청담감지매여간공능변화수치,진행통계학처리,P<0.05위차이현저. 결과 전부사망병례담감지매하강명현( P<0.05 ) ,우기시유선암환자(P<0.001).담감지매승고46례,점5.2%. 전부사망병례제식관、 위암급혈액골수종류,、외상급비뇨생식계통질병곡병전안매변화불명현 ( P>0.05 ) ,여균차이현저( P<0.05 ). 192례간공능정상,점23.8%. 결론 혈청담감지매지속하강,특별시하강폭도대우30%,제시예후불량. 혈청담감지매측정가작위림상병정감측여판단예후적일충지표,치득추엄응용급진일보연구. 기하강궤제가능여간신공능수손、염증반응급궤체주동조절유관. 담감지매승고궤제불명,수진일보탐토.
Objective To investigate the correlation between changes in serum cholinesterase and clinical progno-sis.Methods A retrospective analysis of hospital inpatient 2009.12~2014.12 1099 cases of deaths, 884 cases with complete data , divided between tumor and non-tumor group, serum cholinesterase and liver function numerical analysis by the system statistics before the patient died one week,three weeks, P<0.05 was considered significant.Results All of deaths cholinesterase decreased significantly (P<0.05), especially in patients with breast cancer (P<0.001).Cho-linesterase increased 46 cases, accounting for 5.2%of all deaths in addition to the esophagus, stomach and blood mar-row , trauma and genitourinary system diseases alanine aminotransferase did not change significantly ( P>0.05 ) , the others were significantly different ( P <0.05 ).192 patients with normal liver function, accounting for 23.8%. Conclusions The serum cholinesterase continued to decline, in particular, declined more than 30%, suggesting a poor prognosis.Determination of serum cholinesterase can be used as an indicator to determine the clinical disease surveil-lance and prognosis determined, and further research and widely applied should be done in the future .The mechanism may be related the decline in liver and renal function, inflammation and active regulation of the body.Cholinesterase ele-vated mechanism is unknown, should be further explored.